These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23910532)

  • 1. From plasma transfusion to individualized, goal-directed coagulation factor administration.
    Spahn DR
    J Cardiothorac Vasc Anesth; 2013 Aug; 27(4 Suppl):S16-9. PubMed ID: 23910532
    [No Abstract]   [Full Text] [Related]  

  • 2. Coagulation management in trauma-associated coagulopathy: allogenic blood products versus coagulation factor concentrates in trauma care.
    Klages M; Zacharowski K; Weber CF
    Curr Opin Anaesthesiol; 2016 Apr; 29(2):245-9. PubMed ID: 26784352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thresholds for Perioperative Administration of Hemostatic Blood Components and Coagulation Factor Concentrates: An Unmet Medical Need.
    Bolliger D; Mauermann E; Tanaka KA
    J Cardiothorac Vasc Anesth; 2015; 29(3):768-76. PubMed ID: 26009289
    [No Abstract]   [Full Text] [Related]  

  • 4. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study.
    Görlinger K; Dirkmann D; Hanke AA; Kamler M; Kottenberg E; Thielmann M; Jakob H; Peters J
    Anesthesiology; 2011 Dec; 115(6):1179-91. PubMed ID: 21970887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hemorrhage in trauma.
    Schöchl H; Grassetto A; Schlimp CJ
    J Cardiothorac Vasc Anesth; 2013 Aug; 27(4 Suppl):S35-43. PubMed ID: 23910535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of thrombelastography to guide posttraumatic hemostatic therapy: More coagulation factor concentrates and less allogenic blood transfusion?].
    David JS; Imhoff E; Parat S; Augey L; Geay-Baillat MO; Incagnoli P; Tazarourte K
    Transfus Clin Biol; 2016 Nov; 23(4):205-211. PubMed ID: 27616611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and plasma products in the treatment of massive haemorrhage.
    Erber WN; Perry DJ
    Best Pract Res Clin Haematol; 2006; 19(1):97-112. PubMed ID: 16377544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fresh-frozen plasma transfusion in patients with mild coagulation abnormalities at a large Canadian transfusion center.
    Devine DV
    Transfusion; 2007 Apr; 47(4):749. PubMed ID: 17381637
    [No Abstract]   [Full Text] [Related]  

  • 9. Fresh-frozen plasma transfusion in patients with mild coagulation abnormalities at a large Canadian transfusion center.
    Cheng CK; Sadek I
    Transfusion; 2007 Apr; 47(4):748; author reply 749. PubMed ID: 17381635
    [No Abstract]   [Full Text] [Related]  

  • 10. Trauma-associated bleeding: management of massive transfusion.
    Stephens CT; Gumbert S; Holcomb JB
    Curr Opin Anaesthesiol; 2016 Apr; 29(2):250-5. PubMed ID: 26836808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical use of virally inactived plasma. The experience of Blood Transfusion Unit in Mantova, Italy].
    Lepri D; Capuzzo E; Mattioli AV; Dall'Oglio D; Sgarioto V; Terenziani I; Caramaschi G; Manzato F; Franchini M
    Recenti Prog Med; 2013 Mar; 104(3):106-11. PubMed ID: 23548954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of massive transfusion.
    Höcker P; Hartmann T
    Acta Anaesthesiol Scand Suppl; 1997; 111():205-7. PubMed ID: 9421014
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe pediatric blunt trauma--successful ROTEM-guided hemostatic therapy with fibrinogen concentrate and no administration of fresh frozen plasma or platelets.
    Ziegler B; Schimke C; Marchet P; Stögermüller B; Schöchl H; Solomon C
    Clin Appl Thromb Hemost; 2013; 19(4):453-9. PubMed ID: 22964782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed ratio versus goal-directed therapy in trauma.
    Schöchl H; Maegele M; Voelckel W
    Curr Opin Anaesthesiol; 2016 Apr; 29(2):234-44. PubMed ID: 26595548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding.
    Levy JH; Szlam F; Tanaka KA; Sniecienski RM
    Anesth Analg; 2012 Feb; 114(2):261-74. PubMed ID: 21965371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding.
    Fries D
    Transfusion; 2013 Jan; 53 Suppl 1():91S-95S. PubMed ID: 23301979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are we giving enough coagulation factors during major trauma resuscitation?
    Ho AM; Karmakar MK; Dion PW
    Am J Surg; 2005 Sep; 190(3):479-84. PubMed ID: 16105540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma transfusion for patients with severe hemorrhage: what is the evidence?
    Callum JL; Rizoli S
    Transfusion; 2012 May; 52 Suppl 1():30S-7S. PubMed ID: 22578369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of blood products and factor concentrates for coagulation therapy.
    Fritsma MG
    Clin Lab Sci; 2003; 16(2):115-9. PubMed ID: 12757192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a rationale use of frozen plasma for the treatment and prevention of bleeding.
    Tinmouth A
    Transfus Apher Sci; 2012 Jun; 46(3):293-8. PubMed ID: 22521566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.